Page last updated: 2024-11-07

gastrofenzin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gastrofenzin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID146094
SCHEMBL ID11012184
MeSH IDM0187321

Synonyms (15)

Synonym
gastrophenzine
AN5 ,
dzo-200
carbamic acid, (4-(4-chlorophenyl)-1,2,3,4-tetrahydro-2-methyl-8-isoquinolinyl)-, ethyl ester, monohydrochloride
gastrophensin
4-(4-chlorophenyl)-8-(ethoxycarbonylamino)-2-methyl-1,2,3,4-tetrahydroisoquinoline hcl
gastrofensin
gastrofenzin
2-methyl-4-(4-chlorophenyl)-8-((ethoxycarbonyl)amino)-1,2,3,4-tetrahydroisoquinoline
ccris 7599
89845-17-0
SCHEMBL11012184
DTXSID901009018
ethyl hydrogen [4-(4-chlorophenyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-8-yl]carbonimidate--hydrogen chloride (1/1)
ethyl n-[4-(4-chlorophenyl)-2-methyl-3,4-dihydro-1h-isoquinolin-8-yl]carbamate;hydrochloride

Research Excerpts

Toxicity

Gastrofenzin refers to the group of slightly toxic drugs.A risk evaluation has been carried out under conditions of chronic three-month experiment.

ExcerptReferenceRelevance
"kg-1) and to the classification of Hodge & Stemer Gastrofenzin refers to the group of slightly toxic drugs."( [The toxicological characteristics of Gastrofenzin. I. Its acute toxicity (oral, subcutaneous and intravenous)].
Antov, G; Ivanova, N; Khalkova, Zh; Mikhaĭlova, A; Zaĭkov, Kh, 1996
)
0.82
" The applied doses respond respectively to the control doses, 1/100 and 1/20 LD50 of the preparation."( [The toxicological characteristics of Gastrofenzin. II. Its subacute oral toxicity].
Antov, G; Dinoeva, S; Khalkova, Zh; Mikhaĭlova, A; Tasheva, M; Zaĭkov, Kh, 1996
)
0.57
"A risk evaluation has been carried out under conditions of chronic three-month experiment in oral application of Gastrofenzin in doses 1/20, 1/100 and 1/200 LD50 for male and female white rats, respectively 33."( [The toxicological characteristics of Gastrofenzin. III. Its chronic oral toxicity].
Antov, G; Dinoeva, S; Kapurgov, V; Khalkova, Zh; Mikhaĭlova, A; Mitova, S; Popov, T; Tasheva, M; Zaĭkov, Kh, 1996
)
0.78
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]